Home › Funds › Millennium Management › PLX
Millennium Management position in PLX
PROTALIX BIOTHERAPEUTICS INC · Health Care
Latest position (Q2 2026)171.53K sh
Reported value held$399.68K
Portfolio Weight0.00%
First reportedQ2 2022
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 19.22K | $21.00K | New |
| Q1 2023 | 86.70K | $182 | New |
| Q2 2023 | 21.23K | $42.46K | Reduce |
| Q1 2024 | 10.48K | $13.21K | New |
| Q2 2024 | 811.16K | $949.06K | Add |
| Q3 2024 | 373.76K | $381.23K | Reduce |
| Q4 2024 | 387.92K | $729.29K | Add |
| Q1 2025 | 963.01K | $2.47M | Add |
| Q2 2026 | 171.53K | $399.68K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PLX
- BlackRock Inc 4.05M sh · $9.43M · Q2 2026
- Renaissance Technologies 1.10M sh · $2.55M · Q2 2026
- Geode Capital Management 980.00K sh · $2.28M · Q2 2026
- Northern Trust Corp 922.34K sh · $2.15M · Q2 2026
- Goldman Sachs Group 475.92K sh · $1.11M · Q2 2026
- Marshall Wace 452.76K sh · $1.05M · Q2 2026
- Citadel Advisors 379.43K sh · $884.07K · Q2 2026
- Vanguard Group 488.55K sh · $879.39K · Q4 2025
- BNY Mellon 232.99K sh · $542.87K · Q2 2026
- Charles Schwab Investment Management 180.38K sh · $420.29K · Q2 2026
- AQR Capital Management 167.83K sh · $391.04K · Q2 2026